BSE Live
Feb 11, 16:01Prev. Close
375.05
Open Price
378.70
Bid Price (Qty.)
354.80 (2)
Offer Price (Qty.)
354.80 (689)
NSE Live
Feb 11, 15:58Prev. Close
374.45
Open Price
376.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
354.60 (100)
| Cash Flow of Panacea Biotec (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -63.35 | -0.42 | -250.63 | -262.95 | 155.49 | |
| Net CashFlow From Operating Activities | 44.74 | 53.17 | -25.11 | 255.24 | 92.95 | |
| Net Cash Used In Investing Activities | -29.24 | -18.30 | -28.79 | -121.71 | -22.62 | |
| Net Cash Used From Financing Activities | -10.87 | -37.78 | 55.03 | -161.37 | -67.06 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.02 | 0.00 | -0.36 | -0.16 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 4.63 | -2.89 | 1.13 | -28.20 | 3.11 | |
| Cash And Cash Equivalents Begin of Year | 9.50 | 12.39 | 11.26 | 39.35 | 36.24 | |
| Cash And Cash Equivalents End Of Year | 14.13 | 9.50 | 12.39 | 11.15 | 39.35 |
26.12.2025
16.12.2025
27.11.2025
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
26.11.2025
Panacea Biotec Consolidated September 2025 Net Sales at Rs 141.13 crore, down 4.22% Y-o-Y
24.11.2025
Panacea Biotec Standalone September 2025 Net Sales at Rs 90.81 crore, up 18.49% Y-o-Y
11.06.2025
Panacea Biotec Standalone March 2025 Net Sales at Rs 67.90 crore, down 15.52% Y-o-Y
03.06.2025
Panacea Biotec Consolidated March 2025 Net Sales at Rs 132.53 crore, down 2.88% Y-o-Y